2D Structure
loading...
2D chemical structural formula diagram.
3D Structure
loading...
This 3D model represents a theoretically simulated conformation and is for reference only.
Check the
Raltegravir potassium
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
| IUPAC Name | potassium 4-[(4-fluorophenyl)methylcarbamoyl]-1-methyl-2-[2-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]propan-2-yl]-6-oxopyrimidin-5-olate | |
|---|---|---|
| CAS Number | 871038-72-1 | |
| Molecular Formula |
C20H20FN6O5.K |
|
| Molecular Weight (MW) | 482.51 | |
| SMILES | CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)[O-])C(=O)NCC3=CC=C(C=C3)F.[K+] | |
| InChIKey | IFUKBHBISRAZTF-UHFFFAOYSA-M |
|
Concentration
Volume
Mass
|
|---|
Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| DMSO |
96 mg/mL
(198.95 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 10 mg/mL |
| Water | Insoluble |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
- Raltegravir potassium Clinical Trials
- Raltegravir potassium Solubility in DMSO
- Raltegravir potassium Stock Solution
- Raltegravir potassium Storage
- Raltegravir potassium Stability
- Raltegravir potassium Molecular Weight
- Raltegravir potassium SMILES
- Raltegravir potassium CAS Number
- Raltegravir potassium SDS｜MSDS
Note: Technical data last updated: Sep 1, 2026.